These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3959755)

  • 1. Non-opiate and peripheral-opiate cardiovascular effects of morphine in conscious dogs.
    Given MB; Sander GE; Giles TD
    Life Sci; 1986 Apr; 38(14):1299-303. PubMed ID: 3959755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quaternary opiate antagonists lower blood pressure and inhibit leucine-enkephalin responses.
    Giles T; Sander G; Merz H
    Eur J Pharmacol; 1983 Nov; 95(3-4):247-52. PubMed ID: 6197313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An increase in opiate receptor-sites is associated with enhanced cardiovascular depressant, but not respiratory depressant action of morphine.
    Pfeiffer A; Pfeiffer DG; Feuerstein G; Faden AI; Kopin IJ
    Brain Res; 1984 Apr; 296(2):305-11. PubMed ID: 6322927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma catecholamine and cardiovascular responses to morphine and D-ala2-d-leu5-enkephalin in conscious rats.
    Conway EL; Brown MJ; Dollery CT
    Arch Int Pharmacodyn Ther; 1983 Oct; 265(2):244-58. PubMed ID: 6360061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular activities of intravenous methionine-enkephalin-Arg6-Phe7 and methionine-enkephalin-Arg6-Gly7-Leu8 in the conscious dog.
    Sander GE; Giles TD
    Life Sci; 1985 Jun; 36(23):2201-7. PubMed ID: 3889529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of the cardiovascular response to systemic intravenous administration of leucine-enkephalin in the conscious dog.
    Giles TD; Sander GE
    Peptides; 1983; 4(2):171-5. PubMed ID: 6137809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MIF-1 does not act like naloxone in antagonizing the cardiovascular activity of leucine-enkephalin in the conscious dog.
    Sander GE; Kastin AJ; Giles TD
    Pharmacol Biochem Behav; 1982 Dec; 17(6):1301-3. PubMed ID: 6131437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral opiate receptors are not involved in the naloxone-sensitive cardiovascular effects of clonidine in rats.
    Mosqueda-Garcia R; Kunos G
    Brain Res; 1988 Feb; 442(1):119-23. PubMed ID: 2834009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiorespiratory effects and kinetics of intrathecally injected D-Ala2-D-Leu5-enkephalin and morphine in unanesthetized dogs.
    Atchison SR; Durant PA; Yaksh TL
    Anesthesiology; 1986 Dec; 65(6):609-16. PubMed ID: 3098139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spinal opiate modulation of cardiovascular reflexes in the exercising dog.
    Pomeroy G; Ardell JL; Wurster RD
    Brain Res; 1986 Sep; 381(2):385-9. PubMed ID: 3019479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of opiates on male rat sexual behavior may be mediated by opiate receptors outside the central nervous system.
    Agmo A; Rojas J; Vázquez P
    Psychopharmacology (Berl); 1992; 107(1):89-96. PubMed ID: 1317041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender differences in the cardiovascular responses to morphine and naloxone in spinal rats.
    Cruz SL; Rodríguez-Manzo G
    Eur J Pharmacol; 2000 May; 397(1):121-8. PubMed ID: 10844106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-allylnormetazocine: hemodynamic actions and inhibition of leucine-enkephalin hemodynamic activity in conscious dogs.
    Given MB; Sander GE; Lowe RF; Giles TD
    J Pharmacol Exp Ther; 1988 Dec; 247(3):850-6. PubMed ID: 3204519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of leucine-enkephalin with alpha-adrenoceptors in the conscious dog.
    Giles TD; Sander GE
    Chest; 1983 Feb; 83(2 Suppl):364-6. PubMed ID: 6295713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral opioidergic mechanisms do not mediate naloxone's pressor effect in the conscious rabbit.
    Jang W; Schadt JC; Gaddis RR
    Circ Shock; 1993 Feb; 39(2):121-7. PubMed ID: 8490994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular effects of naloxone, naltrexone and morphine in the squirrel monkey.
    Byrd LD
    Life Sci; 1983 Jan; 32(4):391-8. PubMed ID: 6827900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opiate receptor inhibition improves the blunted baroreflex function in conscious dogs with right-sided congestive heart failure.
    Sakamoto S; Liang CS
    Circulation; 1989 Oct; 80(4):1010-5. PubMed ID: 2551535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphine sulfate depression of cardiac function is attenuated by opiate receptor antagonism with naloxone.
    Vargish T; Beamer KC; Daly T; Riggs TR
    Circ Shock; 1987; 23(3):189-95. PubMed ID: 2827907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition by morphine of the cardiovascular and behavioral responses evoked by centrally administered substance P in conscious rats.
    Itoi K; Jost N; Tschöpe C; Culman J; Badoer E; Unger T
    Neuropharmacology; 1994 Feb; 33(2):181-7. PubMed ID: 7518572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of quaternary naloxone on the increased naloxone potency induced by morphine.
    Wong CL; Wai MK
    Clin Exp Pharmacol Physiol; 1984; 11(5):467-71. PubMed ID: 6084569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.